IMCC
IM Cannabis Corp.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IL
$1.98
−10.00%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 41.4M | 54.7M | 54.0M | 48.8M | 54.3M |
| Cost of Revenue | 35.7M | 45.0M | 45.6M | 39.0M | 45.2M |
| Gross Profit | 5.7M | 9.7M | 8.5M | 9.8M | 9.2M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 12.6M | 12.9M | 13.3M | 19.0M | 28.9M |
| General & Admin Expense | 10.9M | 11.6M | 11.3M | 16.3M | 25.8M |
| Selling & Marketing Expense | 1.7M | 1.3M | 2.0M | 2.8M | 3.1M |
| Other Expenses | 3.9M | 8.3M | 5.4M | 3.6M | 11.0M |
| Total Operating Expenses | 16.5M | 21.3M | 18.7M | 22.6M | 40.0M |
| Cost and Expenses | 52.1M | 66.3M | 64.3M | 61.6M | 85.1M |
| Operating Income (EBIT) | (10.7M) | (11.6M) | (10.2M) | (12.8M) | (30.8M) |
| Non-Operating | |||||
| Interest Income | 1.6M | — | 1.9M | 7.0M | 6.7M |
| Interest Expense | 4.9M | 2.8M | 4.5M | 3.7M | 2.0M |
| Net Interest Income | (3.3M) | (2.8M) | (2.6M) | 3.3M | 4.7M |
| Other Non-Op Income/Expense | (5.6M) | (71.0K) | (2.6M) | 3.3M | 4.7M |
| Non-Operating Income (excl Interest) | (575.0K) | (2.7M) | (1.9M) | (7.0M) | (6.7M) |
| EBT (Pre-Tax Income) | (16.3M) | (11.7M) | (12.8M) | (9.5M) | (26.1M) |
| Income Tax Expense | 57.3K | 92.0K | (1.0M) | 771.0K | (1.1M) |
| Bottom Line | |||||
| Net Income | (15.8M) | (11.3M) | (10.6M) | (9.5M) | (188.9M) |
| Earnings from Cont. Ops | (16.4M) | (11.8M) | (11.8M) | (10.2M) | (24.9M) |
| Earnings from Discont. Ops | — | — | — | — | (166.4M) |
| Bottom Line Net Income | (15.8M) | (11.3M) | (10.6M) | (9.5M) | (188.9M) |
| Per Share | |||||
| Basic EPS | ($34.37) | ($80.10) | ($135.30) | ($133.50) | ($4,734.00) |
| Diluted EPS | ($34.37) | ($80.10) | ($135.30) | ($133.50) | ($4,856.40) |
| Revenue Per Share | $4.46 | $387.31 | $689.99 | $685.30 | $1,361.98 |
| Shares | |||||
| Basic Shares Outstanding | 9.3M | 141310 | 78307 | 71216 | 39894 |
| Diluted Shares Outstanding | 9.3M | 141310 | 78307 | 71216 | 39894 |
| Profitability Metrics | |||||
| EBITDA | (8.3M) | (6.9M) | (6.1M) | (2.8M) | (16.8M) |
| D&A | 1.8M | 2.0M | 2.2M | 3.0M | 7.3M |
| EBIT | (10.2M) | (8.9M) | (8.3M) | (5.8M) | (24.1M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026